Scientists at Pohang University of Science and Technology (POSTECH) and ShanghaiTech University have achieved a breakthrough ...

Arun Swaminathan assumes new role as chief executive officer of Coya Therapeutics: Houston Tuesday, November 5, 2024, 11:00 ...

Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute deterioration of liver function ...

Recurrent pregnancy loss can be devastating and exert a major impact on women, their partners, and society more broadly, but currently there are few options for effective therapies.

Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regu ...

COYA 301 is the company’s proprietary investigational low-dose interleukin-2 (IL-2) intended to enhance the anti-inflammatory function of regulatory T cells (Tregs) and is designed for subcutaneous ...

Liver failure encompasses a range of severe clinical syndromes resulting from the deterioration of liver function, triggered ...

The intricate cellular details of pregnancy demonstrate the complexity of a developing fetus. In the medical community, pregnancy is considered a host-graf | Immunology ...